Literature DB >> 15611375

Clinical utility of serial and continuous ST-segment recovery assessment in patients with acute ST-elevation myocardial infarction: assessing the dynamics of epicardial and myocardial reperfusion.

Mitchell W Krucoff1, Per Johanson, Ricardo Baeza, Suzanne W Crater, Mikael Dellborg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15611375     DOI： 10.1161/01.CIR.0000150401.54856.D3

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  ST-elevation no myocardial infarction.

Authors:  Peter Damman; Robbert J de Winter; Mitchell W Krucoff
Journal:  J Thromb Thrombolysis       Date:  2017-04       Impact factor: 2.300

2.  ST-segment resolution prior to primary percutaneous coronary intervention is a poor indicator of coronary artery patency in patients with acute myocardial infarction.

Authors:  Niels J Verouden; Joost D Haeck; Karel T Koch; José P Henriques; Jan Baan; René J van der Schaaf; Marije M Vis; Ron J Peters; Arthur A Wilde; Jan J Piek; Jan G Tijssen; Robbert J de Winter
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-04       Impact factor: 1.468

3.  Does continuous ST-segment monitoring add prognostic information to the TIMI, PURSUIT, and GRACE risk scores?

Authors:  Pedro Carmo; Jorge Ferreira; Carlos Aguiar; António Ferreira; Luís Raposo; Pedro Gonçalves; João Brito; Aniceto Silva
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-07       Impact factor: 1.468

4.  Early versus late ST-segment resolution and clinical outcomes after percutaneous coronary intervention for acute myocardial infarction.

Authors:  H B van der Zwaan; M G Stoel; J W Roos-Hesselink; G Veen; E Boersma; C von Birgelen
Journal:  Neth Heart J       Date:  2010-09       Impact factor: 2.380

5.  The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction.

Authors:  S G Foussas; M N Zairis; S S Makrygiannis; S J Manousakis; F A Anastassiadis; C S Apostolatos; N G Patsourakos; M P Glyptis; J K Papadopoulos; D C Xenos; E N Adamopoulou; C D Olympios; S K Argyrakis
Journal:  Heart       Date:  2007-03-07       Impact factor: 5.994
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.